Innovation, research, and the future: biotechnology sets the course for psoriasis treatmen... 29/10/2025 Inhibitec Anticuerpos Biotechnology enables the development of more effective and personalized treatments for chronic inflammatory diseases... AseBio - Inhibitec Anticuerpos
When biotechnology puts itself in the patient’s skin 29/10/2025 Healthcare Access to innovation Innovative drugs The biotech company Inhibitec is advancing the development of an antibody targeting the BAMBI molecule, with therapeutic... AseBio - Inhibitec Anticuerpos
Personalized Vaccines, CAR-T, and AI: The New Horizon of Cancer Research 24/09/2025 Healthcare Innovative drugs Personalized medicine Advanced therapies On World Cancer Research Day, the AECC Scientific Foundation reminds us that only through the joint commitment of... AseBio - Fundación Científica de la Asociación Española Contra el Cáncer
Personalized Vaccines, CAR-T, and AI: The New Horizon of Cancer Research 24/09/2025 Fundación Científica de la Asociación Española Contra el Cáncer Cancer research is advancing thanks to biotechnology, but it still faces challenges such as equitable access and the... AseBio - Fundación Científica de la Asociación Española Contra el Cáncer
ORYZON strengthens patent portfolio for iadademstat and vafidemstat with new Decisions to ... 16/09/2025 Healthcare Access to innovation Innovative drugs Oryzon Genomics S.A., a clinical-stage biopharmaceutical company and European leader in epigenetics, has strengthened... Partners - Oryzon Genomics
SPEEDCELL, the new European project led by HIPRA, aims to reduce vaccine and biologics dev... 04/09/2025 Healthcare Access to innovation Innovative drugs With a duration of 4 years, this EU4Health program project aims to contribute to strengthening global health response... Partners - HIPRA HUMAN HEALTH S.L.U.
Pterovita® and Pteroyouth®: Spanish biotechnology for cell resilience and chronic disease ... 03/09/2025 Healthcare Access to innovation Innovative drugs CIRCE Health Science has developed Pterovita® and Pteroyouth®, ingredients that combine the application of crystal... Partners - BIOIB
AbilityPharma’s IBRILATAZAR (ABTL0812) doubles overall survival in patients with squamous ... 05/06/2025 Healthcare Innovative drugs Advanced therapies These results support ibrilatazar as a potential backbone therapy for patients with one of the most common subtypes of... Partners - Ability Pharmaceuticals
Accelerating molecular discovery using an in silico design platform 08/07/2025 Healthcare Access to innovation Drug discovery Innovative drugs Advanced therapies Industrial biotechnology Join our free event on Tuesday, July 8th at the Parque Científico de Barcelona for an extended version of our Lunch and... Partners - SCHRÖDINGER GMBH
BioDuro hosts webinar: "Exploring Peptide In-Vitro ADME Properties – From Natural Peptides... 30/05/2025 Healthcare Drug discovery Innovative drugs Advanced therapies The webinar exploring the in-vitro ADME (Absorption, Distribution, Metabolism, and Excretion) properties of peptide... Partners - BIODURO
